Liability related to sale of future revenues, non-current
63,414
61,306
Other long-term liabilities
98
106
Long-term liabilities held for sale
0
156
Total liabilities
119,529
359,085
Redeemable non-controlling interests
21,480
21,480
Common stock, 0.01 par value 225,000 shares authorized at september 30, 2025 and december 31, 2024 4,045 and 4,037 shares issued and outstanding at september 30, 2025 and december 31, 2024
1,011
1,011
Additional paid-in capital
1,675,999
1,673,249
Accumulated other comprehensive loss
-2,211
-4,794
Accumulated deficit
-1,691,827
-1,892,463
Total stockholders' deficit attributable to fibrogen
-17,028
-222,997
Nonredeemable non-controlling interests
13,033
20,487
Total deficit
-3,995
-202,510
Total liabilities, redeemable non-controlling interests and deficit
137,014
178,055
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Time Plot
Show the time plot by selecting a row from the table.